| Symbol |
Name |
|
ACSL3
|
acyl-CoA synthetase long-chain family member 3
|
|
ACTN4
|
actinin, alpha 4
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ARF1
|
ADP-ribosylation factor 1
|
|
ATRN
|
attractin
|
|
AURKA
|
aurora kinase A
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
CA2
|
carbonic anhydrase II
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD19
|
CD19 molecule
|
|
CD274
|
CD274 molecule
|
|
CD300A
|
CD300a molecule
|
|
CD38
|
CD38 molecule
|
|
CD81
|
CD81 molecule
|
|
CDKL5
|
cyclin-dependent kinase-like 5
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTAG2
|
cancer/testis antigen 2
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
DCN
|
decorin
|
|
EBNA1BP2
|
EBNA1 binding protein 2
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ETV6
|
ets variant 6
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBN1
|
fibrillin 1
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FHIT
|
fragile histidine triad
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOXP3
|
forkhead box P3
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GLO1
|
glyoxalase I
|
|
HEPH
|
hephaestin
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HOXD13
|
homeobox D13
|
|
HOXD9
|
homeobox D9
|
|
IFNG
|
interferon, gamma
|
|
IGH
|
immunoglobulin heavy locus
|
|
IL13
|
interleukin 13
|
|
IL17A
|
interleukin 17A
|
|
IL1A
|
interleukin 1, alpha
|
|
IL2
|
interleukin 2
|
|
IL3
|
interleukin 3
|
|
IL4
|
interleukin 4
|
|
JAG1
|
jagged 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIR3DL2
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRT10
|
keratin 10, type I
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LEPR
|
leptin receptor
|
|
LRG1
|
leucine-rich alpha-2-glycoprotein 1
|
|
LRRC32
|
leucine rich repeat containing 32
|
|
MAGEC2
|
melanoma antigen family C2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGEA5
|
meningioma expressed antigen 5 (hyaluronidase)
|
|
MLANA
|
melan-A
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
NGFR
|
nerve growth factor receptor
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NOTCH1
|
notch 1
|
|
NT5C2
|
5'-nucleotidase, cytosolic II
|
|
P2RY8
|
purinergic receptor P2Y, G-protein coupled, 8
|
|
PCM1
|
pericentriolar material 1
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PIGA
|
phosphatidylinositol glycan anchor biosynthesis, class A
|
|
PMEL
|
premelanosome protein
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PTX3
|
pentraxin 3, long
|
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
SIRT1
|
sirtuin 1
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SNRNP70
|
small nuclear ribonucleoprotein 70kDa (U1)
|
|
SOCS2
|
suppressor of cytokine signaling 2
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1
|
|
TBX21
|
T-box 21
|
|
TERT
|
telomerase reverse transcriptase
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TLR3
|
toll-like receptor 3
|
|
TNF
|
tumor necrosis factor
|
|
TP53
|
tumor protein p53
|
|
TRD
|
T cell receptor delta locus
|
|
TYMS
|
thymidylate synthetase
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
WAS
|
Wiskott-Aldrich syndrome
|